TriangleCANCER EVIDENCE
Conditional Survival
66 published cancer groups · 255,360 source series. Choose a group to explore its populations.
Acute Lymphocytic Leukemia (ALL)
Acute Monocytic Leukemia (AML-M5)
Acute Myeloid Leukemia (AML)
Adenocarcinoma of the Esophagus
Adenocarcinoma of the Lung and Bronchus
All Cancer Sites Combined
Anus, Anal Canal & Anorectum
Bones and Joints
Brain and Other Nervous System
Breast
Cervix Uteri
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloid Leukemia (CML)
Chronic Myelomonocytic Leukemia (CMML)
Chronic myeloproliferative disorders (CMD)
Colon (including Appendix)
Colon and Rectum (excluding Appendix)
Colon and Rectum (including Appendix)
Corpus and Uterus, NOS
Diffuse Astrocytoma and Anaplastic Astrocytoma of the Brain and ONS
Embryonal Tumors of the Brain and ONS
Esophagus
Eye and Orbit
Floor of Mouth
Follicular Subtype of the Thyroid
Gallbladder
Glioblastoma of the Brain and ONS
Gum & other mouth
Hodgkin Lymphoma
Kaposi Sarcoma
Kidney
Kidney and Renal Pelvis
Large Cell Carcinoma of the Lung and Bronchus
Larynx
Leukemia
Lip
Liver and Intrahepatic Bile Duct
Lung and Bronchus
Melanoma of the Skin
Meningioma of the Brain and ONS
Mesothelioma
Myelodysplastic syndromes (MDS)
Myeloma
Non-Hodgkin Lymphoma
Oral Cavity and Pharynx
Oropharynx & Tonsil
Other Glioma of the Brain and ONS
Ovary
Pancreas
Papillary Subtype of the Thyroid
Prostate
Rectum
Renal Pelvis
Salivary Gland
Small cell carcinoma of the Lung and Bronchus
Small Intestine
Soft Tissue including Heart
Squamous Cell Carcinoma of the Esophagus
Squamous Cell Carcinoma of the Lung and Bronchus
Stomach
Testis
Thyroid
Tongue
Urinary Bladder (Invasive & In Situ)
Vagina
Vulva
Preserved source evidence · Independent clinical review pending · Not medical advice